Sporadic cerebral amyloidotic angiopathy;Angiopathie amyloïde cérébrale sporadique

Revue Neurologique

Volumn 162, Issue 11, 2006, Pages 1059-1067

  Cabrejo, L ^a   Chassagne, P ^a   Doucet, J ^a   Laquerriere A ^a   Puech, N ^a   Hannequin, D ^a,b  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Amyloid angiopathy; Dementia; Elderly; Intracerebral hemorrhage; Leukoencephalopathy; Microbleeds

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; CYCLOPHOSPHAMIDE; TICLOPIDINE;

ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CEREBELLUM HEMORRHAGE; CLINICAL FEATURE; DEMENTIA; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GENOTYPE; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HUMAN; MORBIDITY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROPHYLAXIS; REVIEW; RISK FACTOR; VASCULAR AMYLOIDOSIS;

EID: 33750696634     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(06)75118-9     Document Type: Review

References (73)

1. ALONZO NC, HYMAN BT, REBECK GW, GREENBERG SM. (1998). Progression of cerebral amyloid angiopathy. Accumulation of amyloid-40 in already affected vessels. J Neuropathol Exp Neurol, 57: 353-359.
2. ACCP. (2004). Hemorrhagic complications of anticoagulant treatment: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126: 287s-310s.
3. ATTEMS J, JELLINGER K. (2004). Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology: a pilot study. Acta Neuropathol, 107: 83-90.
4. BAILEY RD, HART RG, BENAVENTE O, PEARCE LA. (2001). Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology, 56: 773-777.
5. BUTCHER K, LAIDLAW JOHN. (2003). Current intracerebral haemorrhage management. J Clin Neurosci, 10: 158-167.
6. CADAVID D, MENA H, KOELLER K, FROMMELT RA. (2000). Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsy. J neuropathol Exp Neurol, 59: 768-773.
7. CORDER EH, SAUNDERS AM, RISCH NJ et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet, 7: 180-184.
8. DE BROUCKER T, HENIN D, CLAQUIN G et al. (2000). Angiopathie amyloïde cérébrale à présentation pseudo-tumorale : 2 cas d'évolution spontanément favorable. Rev Neurol (Paris), 156: 747-751.
9. DERMAUT B, KUMAR-SINGH S, DE JONGHE C et al. (2001). Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation. Brain, 124: 2383-2392.
10. DUBAS F, GRAY F, ROULLET E, ESCOUROLLE R. (1985). Leucoencé phalopathies artériopathiques. 17 observations anatomocliniques. Rev Neurol (Paris), 141: 93-108.
11. DUBAS F. (2003). Small vessel pathology and cerebral hemorrhage. J Neuroradiol, 30: 298-302.
12. ECKMAN M, ROSAND J, KNUDSEN K, SINGER D, GREENBERG S. (2003). Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke, 34: 1710-1716.
13. ELLIE E, CAMOU F, VITAL A et al. (2001). Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology, 57: 135-137.
14. ELLIS RJ, OLICHNEY JM, THAI LJ et al. (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer disease: the CERAD experience. Part XV. Neurology, 46: 1592-1596.
15. ENG JA, FROSCH MP, CHOI K, REBECK GW, GREENBERG SM. (2004). Clinical manifestations of cerebral amyloid angiopathy - related inflammation. Ann Neurol, 55: 250-256.
16. FANG MC, CHANG Y, HYLEK EM et al. (2004). Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med, 141: 745-752.
17. FOUNTAIN NB, LOPES MB. (1999). Control of primary angiitis of the CNS associated with cerebral amyloid angiopathy by cyclophosphamide alone. Neurology, 52: 660-662.
18. GREENBERG SM, VONSATTEL J, STAKES J, GRUBER M, FINKLESTEIN S. (1993). The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology, 43: 2073-2079.
19. GREENBERG SM, REBECK GW, VONSATTEL JPG, GOMEZ-ISLA T, HYMAN BT. (1995). Apolipoprotein E 4 and cerebral hemorrhage associated with Amyloid Angiopathy. Ann Neurol, 38: 254-259.
20. GREENBERG SM, FINKLESTEIN S, SCHAEFER P. (1996). Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology, 46: 1751-1754.
21. GREENBERG SM, VONSATTEL J. (1997). Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy? Stroke, 28: 1418-1422.
22. GREENBERG SM, VONSATTEL JPG, SEGAL AZ et al. (1998). Association of apolipoprotein E 2 and vasculopathy in cerebral amyloid angiopathy. Neurology, 50: 961-965.
23. GREENBERG SM, SHIN Y, GRABOWSKI TJ et al. (2003). Hemorrhagic stoke associated with Iowa amyloid precursor protein mutation. Neurology, 60: 1020-1022.
24. GREENBERG SM, GUROL M, ROSAND J, SMITH E. (2004a). Amyloid angiopathy-related vascular cognitive impairment. Stroke, 35: 2616-2619.
25. GREENBERG SM, ENG JA, NING M, SMITH EE, ROSAND J. (2004b). Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke, 35: 1415-1420.
26. HANKEY GJ, SUDLOW CL, DUNBABIN DW. (2000). Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke, 31: 1779-1784.
27. HART R, PEARCE L, ROTHBART R et al. (2000). Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. JACC, 35: 183-187.
28. HAUW J, ZEKRY D, SEILHEAN D et al. (2002). Neuropathology of the cerebral vessels of centenarians. J Mal Vasc, 27: S13-S18.
29. HENON H, PASQUIER F, DURIEU L et al. (1997). Preexisting dementia in stroke patients. Stroke, 28: 2429-2436.
30. HUANG W, QIU C, VON STRAUSS E, WINBLAD B, FRATIGLIONI L. (2004). APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol, 61: 1930-1934.
31. ITOH Y, YAMADA M, SUEMATSU N, MATSUSHITA M, OTOMO E. (1996). Influence of Apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly. Stroke, 27: 216-218.
32. ITOH Y, YAMADA M. (1997). Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. J Med Dent Sci, 44: 11-19.
33. IZUMIHARA A, ISHIHARA T, IWAMOTO N, YAMASHITA K, ITOH H. (1999). Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke, 30: 29-33.
34. JEERAKATHIL T, WOLF PA, BEISER A et al. (2004). Cerebral microbleeds. Prevalence and associations with cardiovascular risk factors in the Framingham study. Stroke, 35: 1831-1835.
35. JELLINGER K. (2002). Alzheimer disease and cerebrovascular pathology: an update. J Neurol Transm, 109: 813-836.
36. KNUDSEN KA, ROSAND J, KARLUK D, GREENBERG SM. (2001). Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology, 56: 537-539.
37. LEE SH, PARK JM, KWON SJ et al. (2004). Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients. Neurology, 13: 16-21.
38. LESNIK OBERSTEIN S, VAN DEN BOOM R, VAN BUCHEM M et al. (2001). Cerebral microbleeds in CADASIL. Neurology, 57: 1066-1070.
39. LOVE S, NICOLL J, HUGHES A, WILCOCK G. (2003). APOE and cerebral amyloid angiopathy in the elderly. NeuroReport, 14: 1535-1536.
40. MANNO EM, ATKINSON JL, FULGHAM JR, WIJDICKS EF. (2005). Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Pro, 80: 420-433.
41. MCCARRON M, NICOLL J. (1998). High frequency of apolipoprotein E 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci Le, 247: 45-48.
42. MCCARRON M, NICOLL J, IRONSIDE J, LOVE S, ALBERTS M, BONE I. (1999a). Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE 2 with putative clinical risk factors. Stroke, 30: 1643-1646.
43. MCCARRON M, NICOLL J, LOVE S, IRONSIDE J. (1999b). Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy-related haemorrhage. Br J Neurosurg, 13: 426-427.
44. MCCARRON M, NICOLL AR. (2004). Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet, 3: 484-492.
45. MILLER JH, WARDLAW JM, LAMMIE GA. (1999). Intracerebral haemorrhage and cerebral amyloid angiopathy: CT features with pathological correlation. Clin Radiol, 54: 422-429.
46. NEUROPATHOLOGY GROUP OF THE MRC CFAS. (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet, 357: 169-175.
47. NICOLL J, BURNETT C, LOVE S et al. (1997). High frequency of apolipoprotein E 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol, 41: 716-721.
48. O'DONNELL H, ROSAND J, KNUDSEN K et al. (2000). Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med, 27: 240-245.
49. OH U, GUPTA R, KRAKAUER JW, KHANDJI AG, CHIN SS, ELKIND MS. (2004). Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology, 62: 494-497.
50. OHTANI R, KAZUI S, TOMIMOTO H, MINEMATSU K, NARITOMI H. (2003). Clinical and radiographic features of lobar cerebral hemorrhae : hypertensive versus non-hypertensive cases. Intern Med, 42: 576-580.
51. OIDE T, TAKAHASHI H, YUTANI C, ISHIHARA T, IKEDA S. (2003). Relationship between lobar intracerebral hemorrhage and leukoencephalopathy associated with cerebral amyloid angiopathy: clinicopathological study of 64 japanese patients. Amyloid, 10: 136-143.
52. OLICHNEY JM, HANSEN LA, HOFSTETTER CR, GRUNDMAN M, KATZMAN R, THAL LJ. (1995). Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol, 52: 702-708.
53. OTT A, BRETELER M, DE BRUYNE M, VAN HARSKAMP F, GROBBEE D, HOFMAN A. (1997). Atrial fibrillation and dementia in a population-based study. Stroke, 28: 316-321.
54. PEYSSON S, NIGHOGHOSSIAN N, DEREX L, JOUVET A, HERMIER M, TROUILLAS P. (2003). Angiopathie amyloïde cérébrale révé lée par des accidents neurologiques transitoires. Intérêts diagnostiques et physiopathologiques de l'IRM. Rev Neurol (Paris), 159: 203-205.
55. PFEIFER LA, WHITE LR, ROSS GW, PETROVITCH H, LAUNER LJ. (2002). Cerebral amyloid angiopathy and cognitive function. The HAAS autopsy study. Neurology, 58: 1629-1634.
56. PREMKUMAR D, COHEN D, HEDERA P, FRIEDLAND R, KALARIA R. (1996). Apolipoprotein E 4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Path, 148: 2083-2094.
57. REVESZ T, GHISO J, LASHLEY T et al. (2003). Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol, 62: 885-898.
58. ROVELET-LECRUX A, HANNEQUIN D, RAUX G et al. (2005). APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet, in press.
59. SCOLDING NJ, JOSEPH F, KIRBY PA et al. (2005). A(beta)-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain, 128: 500-515.
60. SMITH E, GREENBERG S. (2003). Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston Criteria. Current Atherosclerosis Reports, 5: 260-266.
61. SAUNDERS A, STRITTMATTER W, SCHMECHEL D et al. (1993). Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43: 1467-1472.
62. TAKEDA S, YAMAZAKI K, MIYAKAWA T et al. (2003). Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space? Neuropathology, 23: 254-261.
63. TIAN J, SHI J, BAILEY K, LENDON CL, PICKERING-BROWN SM, MANN DM. (2004). Association between apolipoprotein E 4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 75: 696-699.
64. VINTERS HV, GILBERT JJ. (1983). Cerebral amyloid angiopathy: incidence and complications in the aging brain. Stroke, 14: 924-928.
65. VINTERS H, NATTÉ R, MAAT-SCHIEMAN M et al. (1998). Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol, 95: 235-244.
66. VONSATTEL J, MYERS R, HEDLEY-WHYTE E, ROPPER A, BIRD E, RICHARDSON E. (1991). Cerebral amyloid angiopathy without and with cerebral hemorrhage comparative histological study. Ann Neurol, 30: 637-649.
67. WANG Y, KLUNK WE, DEBNATH ML et al. (2004). Development of a PET/Spect agent for amyloid imaging in Alzheimer's disease. J Mol Neurosci, 24: 55-62.
68. XU D, YANG C, WANG L. (2003). Cerebral amyloid angiopathy in aged Chinese: a clinico-neuropathological study. Acta Neuropathol (Berl), 106: 89-91.
69. YAMADA M. (2000). Cerebral amyloid angiopathy: an overview. Neuropathology, 1: 8-22.
70. YAMADA M, TSUKAGOSHI H, OTOMO E, HAYAKAWA M. (1987). Cerebral amyloid angiopathy in the aged. J Neurol, 234: 371-376.
71. YAMADA M. (2004). Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci, 226: 41-44.
72. ZEKRY D, DUYCKAERTS C, BELMIN J, GEOFFRE C, MOULIAS R, HAUW J. (2003). Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia. Acta Neuropathol, 106: 367-373.
73. ZHAN R, TONG Y, SHEN J et al. (2004). Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorraghe. J Zhejiang Univ Sci, 5: 1262-1269.